Drugmakers pledge to prioritize safety; WHO says ‘this will not be the last
Nine drugmakers working on coronavirus vaccines publicly pledged on Tuesday to prioritize safety and uphold rigorous scientific standards as concerns mount of political pressure to bring a vaccine to market before the Nov. 3 U.S. presidential election. The pledge sought to “ensure public confidence” by committing to only apply for regulatory authorization when enough data has been collected from a large phase three trial. Three vaccine manufacturers have now entered phase three trials.
The following data was compiled by Johns Hopkins University:
- Global cases: More than 27.3 million
- Global deaths: At least 893,00
- U.S. cases: More than 6.3 million
- U.S. deaths: At least 189,200
Read More: Drugmakers pledge to prioritize safety; WHO says ‘this will not be the last